Medical advances improve bile duct cancer outcomes

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/medical-advances-improve-bile/id4318... Patients with cholangiocarcinoma (bile duct cancer), show no signs of the disease early on. Bile duct cancer usually presents at an advanced stage, which carries a poor prognosis. New advances in medical treatment offer hope. Milind Javle, M.D., associate professor in Gastrointestinal Medical Oncology at MD Anderson Cancer Center, discusses new therapies for bile duct cancer, including,...

Gallbladder cancer: rare and often misdiagnosed

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/gallbladder-cancer-rare-often/id4318... Gallbladder cancer is often misdiagnosed as liver cancer and is difficult to detect early since there are no symptoms at onset. Approximately 5,000 cases are diagnosed in the United States each year, but incidence is increasing with young Latinos in the southern part of the country. Listen to Milind Javle, M.D., associate professor in Gastrointestinal Medical Oncology at MD Anderson Cancer...

Hope on the Horizon for Pancreatic Cancer Patients

submitted by: mdanderson
Clinical Trial: http://1.usa.gov/PncreasCncr Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer. Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory. Javle says it is believed that every pancreatic...